Dr Georgios K Dimitriadis

Dr Georgios K Dimitriadis is a Consultant in Endocrinology and Obesity Medicine at King's College Hospital NHS Foundation Trust and Honorary Senior Lecturer in the School of Cardiovascular Medicine & Sciences at King's.

He was awarded an MSc on Reproductive Endocrinology from the University of Athens for his work on the "effects of testosterone replacement therapy on energy expenditure of hypogonadal men". He was also awarded an MSc on Obesity and related comorbidities from Karolinska Institute for his work on the "effect of bariatric surgery on Natural Killer cell activity in adult humans". His PhD thesis for the University of Warwick is on the "cardioprotective effects of medical and surgical interventions for the management of obesity". Georgios is the lead physician for Tier 4 ASO/EASO COM Bariatric and Metabolic Surgery Services across KCH, PRUH and South Sites.

His areas of research interest involve clinical and preclinical studies on medical, endoscopic and surgical interventions for the management of obesity and related disorders (prediabetes, PCOS, CVD, NAFLD/NASH). Georgios is an investigator in several landmark obesity and T2DM studies (SCALE, LEADER, EXSCEL, STEP-1, DUAL-VIII, SUSTAIN 6 &10, AMYLIN, SELECT, SOUL and others).

He has received several awards and scholarships from SfE-BES, UEMS, Novo Nordisk UK Research Foundation and recently NIHR South London CRN Strategic "Green Shoots" Investigator award in recognition of his clinical research outcomes. Dr Dimitriadis has graduated the 3rd European Obesity Academy (Karolinska/J&J) and UK 1st Emerging Obesity Leaders Programme (NN/ASO). He is a SCOPE and EASO UK National Fellow.

He is a member of the All Party Parliamentary Group on Obesity and RCP advisory group on the new guideline for obesity management. Georgios is a trustee board of directors The Association for the Study of Obesity (ASO) and member of the clinical and science sub-committees Society for Endocrinology-British Endocrine Society (SfE-BES).